2019
DOI: 10.1016/j.jim.2018.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Development of a robust and standardized immunoserological assay for detection of anti-measles IgG antibodies in human sera

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
21
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(29 citation statements)
references
References 28 publications
6
21
0
2
Order By: Relevance
“…Anti-measles antibody (IgG)-level data were considered an adequate model for pathogen-derived (or infection-induced) antibodies that are present in the great majority of the Hungarian population. Based on our previous findings [20,21] and in accordance with data of other Hungarian colleagues [22,23], the overall ratio of the Hungarian population in possession of sufficient anti-measles IgG antibody levels is ≈90%, with a well-characterized, more susceptible cluster being responsible for the lagging ≈10%. Age group categorization based on historical changes in the measles, mumps and rubella (MMR) immunization schedule, recurring epidemics, subsequent revaccination protocols and shifts between vaccine valency (mono-, bi-or trivalent) and manufacturers have been thoroughly detailed previously [20,21,24].…”
Section: Anti-measles Igg Elisasupporting
confidence: 88%
“…Anti-measles antibody (IgG)-level data were considered an adequate model for pathogen-derived (or infection-induced) antibodies that are present in the great majority of the Hungarian population. Based on our previous findings [20,21] and in accordance with data of other Hungarian colleagues [22,23], the overall ratio of the Hungarian population in possession of sufficient anti-measles IgG antibody levels is ≈90%, with a well-characterized, more susceptible cluster being responsible for the lagging ≈10%. Age group categorization based on historical changes in the measles, mumps and rubella (MMR) immunization schedule, recurring epidemics, subsequent revaccination protocols and shifts between vaccine valency (mono-, bi-or trivalent) and manufacturers have been thoroughly detailed previously [20,21,24].…”
Section: Anti-measles Igg Elisasupporting
confidence: 88%
“…The samples are considered representative, as clinical residual samples were randomly selected (with the exclusion of seriously immunocompromised patients) from the Department of Laboratory Medicine, University of Pécs, Medical School, which serves three counties (Baranya, Somogy and Tolna, with a population of ∼8 87 000), and receives laboratory examination requests from all over Hungary. In case of measles serosurvey, in order to give a more accurate estimate at population level, we combined our recently published data with the results of current measurements (previously we tested 1985 serum samples for measles [24], of which the data of 1787 samples have been pooled together with the current data; 'cumulative' data for measles, N total measles = 3523). Serum samples were from all age groups (beginning from the era before the implementation of measles vaccine, through several different vaccine types, manufacturers and vaccination schedules, up to present), and were categorised based on past changes introduced in measles and MMR immunisation schedules ( Table 1).…”
Section: Samplesmentioning
confidence: 99%
“…Testing of blocking reagents was performed using bovine gelatine, milk powder, Block ACE (Bio-Rad) and our in-house polyvinyl alcohol (PVA)-based purely synthetic blocking buffer. Details of sample pre-treatment and assay preparation steps have been described earlier [24]. To demonstrate the lack of interference when using cell culturederived antigen coatings, we compared our 'target' assay to purified recombinant viral capsid protein antigen-based assays.…”
Section: Antigen Coatingmentioning
confidence: 99%
See 2 more Smart Citations